Literature DB >> 19609427

Multiple fusiform cerebral aneurysms and highly elevated serum interleukin-6 in cardiac myxoma.

Young-Ho Koo1, Tae-Gon Kim, Ok-Joon Kim, Seung-Hun Oh.   

Abstract

Cerebral embolic infarction is the most common neurologic complication of cardiac myxoma (CM). Development of cerebral aneurysms in CM is very rare. We present a 64-year-old woman with acute cerebral infarction and multiple cerebral aneurysms complicated by CM. The aneurysms were multiple, fusiform-shaped, and located in distal branch of major cerebral arteries. The serum interleukin (IL)-6 was highly elevated, which was normalized after surgical resection of CM. There was no regression of aneurysms on follow-up neuroimaging. Multiple cerebral aneurysms in CM are rare condition. Highly elevated serum IL-6 may be associated with increased risk of cerebral aneurysmal formation.

Entities:  

Keywords:  Aneurysm; Interleukin-6; Myxoma

Year:  2009        PMID: 19609427      PMCID: PMC2711241          DOI: 10.3340/jkns.2009.45.6.394

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  10 in total

1.  Late recurrence of left atrial myxoma with multiple intracranial aneurysms.

Authors:  Mehmet Birhan Yilmaz; Yesim Akin; Umit Güray; Halil L Kisacik; Sule Korkmaz
Journal:  Int J Cardiol       Date:  2003-02       Impact factor: 4.164

2.  Correlation of interleukin-6 gene expression to immunologic features in patients with cardiac myxomas.

Authors:  J T Parissis; D Mentzikof; M Georgopoulou; M Gikopoulos; A Kanapitsas; K Merkouris; C Kefalas
Journal:  J Interferon Cytokine Res       Date:  1996-08       Impact factor: 2.607

3.  Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.

Authors:  Augusto Orlandi; Alessandro Ciucci; Amedeo Ferlosio; Antonio Pellegrino; Luigi Chiariello; Luigi Giusto Spagnoli
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

4.  [A case of cardiac myxoma presenting with multiple cerebellar hemorrhages and elevation of interleukin-6 in the cerebrospinal fluid].

Authors:  Hiroshi Yaguchi; Yasuo Murakami; Renpei Sengoku; Hironori Sato; Kiyoharu Inoue
Journal:  Rinsho Shinkeigaku       Date:  2004-10

Review 5.  Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases.

Authors:  L Pinede; P Duhaut; R Loire
Journal:  Medicine (Baltimore)       Date:  2001-05       Impact factor: 1.889

6.  The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence.

Authors:  C E Mendoza; M F Rosado; L Bernal
Journal:  Tex Heart Inst J       Date:  2001

Review 7.  Multiple cerebral aneurysms as delayed complication of left cardiac myxoma: a case report and review.

Authors:  M Sabolek; K Bachus-Banaschak; R Bachus; G Arnold; A Storch
Journal:  Acta Neurol Scand       Date:  2005-06       Impact factor: 3.209

8.  Cardiac myxoma metastasized to the brain: potential role of endogenous interleukin-6.

Authors:  A Wada; T Kanda; R Hayashi; S Imai; T Suzuki; K Murata
Journal:  Cardiology       Date:  1993       Impact factor: 1.869

9.  Central nervous system manifestations of cardiac myxoma.

Authors:  Vivien H Lee; Heidi M Connolly; Robert D Brown
Journal:  Arch Neurol       Date:  2007-08

10.  Histologically verified cerebral aneurysm formation secondary to embolism from cardiac myxoma. Case report.

Authors:  K Furuya; T Sasaki; Y Yoshimoto; Y Okada; T Fujimaki; T Kirino
Journal:  J Neurosurg       Date:  1995-07       Impact factor: 5.115

  10 in total
  11 in total

Review 1.  Delayed intracranial aneurysm formation after cardiac myxoma resection: Report of two cases and review of the literature.

Authors:  Alejandro Santillan; Jared Knopman; Athos Patsalides; Y Pierre Gobin
Journal:  Interv Neuroradiol       Date:  2018-11-04       Impact factor: 1.610

2.  "Metastatic" embolic lesions and enlarging pseudoaneurysms associated with cardiac myxoma.

Authors:  Tatiana Chacón-Quesada; Alberto Maud; Thomas J O'Neill; Luis Ramos-Duran; Nassim Akle; Salvador Cruz-Flores; Gustavo J Rodríguez
Journal:  Neurol Clin Pract       Date:  2015-04

3.  Multiple intracranial aneurysms followed left atrial myxoma: case report and literature review.

Authors:  Qingsheng Xu; Xiaobing Zhang; Pan Wu; Ming Wang; Yongqing Zhou; Yiping Feng
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

4.  Rupture of cerebral myxomatous aneurysm months after resection of the primary cardiac tumor.

Authors:  Christopher S Eddleman; Numa R Gottardi-Littell; Bernard R Bendok; H Hunt Batjer; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

Review 5.  Myxomatous aneurysms: a case report and literature review.

Authors:  E Tamulevičiūtė; P Taeshineetanakul; K Terbrugge; T Krings
Journal:  Interv Neuroradiol       Date:  2011-06-20       Impact factor: 1.610

6.  Intracranial aneurysm disappeared after resection of a cardiac myxoma.

Authors:  Ying Huang; Jianping Chen; Jun Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 7.  The dynamic natural history of cerebral aneurysms from cardiac myxomas: A review of the natural history of myxomatous aneurysms.

Authors:  Paloma Largo Flores; Felix Haglund; Pervinder Bhogal; Leonard Yeo Leong Litt; Michael Södermann
Journal:  Interv Neuroradiol       Date:  2018-01-31       Impact factor: 1.610

8.  Intracardiac Myxoma, Cerebral Aneurysms and Elevated Interleukin-6.

Authors:  Nnadozie Ezerioha; Wuwei Feng
Journal:  Case Rep Neurol       Date:  2015-07-21

Review 9.  Anesthesia management of atrial myxoma resection with multiple cerebral aneurysms: a case report and review of the literature.

Authors:  Ran Zhang; Zhiyu Tang; Qing Qiao; Feroze Mahmood; Yi Feng
Journal:  BMC Anesthesiol       Date:  2020-07-04       Impact factor: 2.217

10.  Coil embolization of an enlarging fusiform myxomatous cerebral aneurysm.

Authors:  Frances Lazarow; Serra Aktan; Karah Lanier; John Agola
Journal:  Radiol Case Rep       Date:  2018-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.